Brands Available Details



Name: Pasireotide

View Drug Forms

Indications & Dose:

Cushing's disease when surgery has failed or is inappropriate


BY SUBCUTANEOUS INJECTION


Adult: Initially 600 micrograms twice daily for 2 months then increased if necessary to 900 micrograms twice daily consider discontinuation if no response within 2 months for dose adjustment due to side effects-consult product literature.

Contraindications:

-

Cautions:

Cardiac disorders (including bradycardia). susceptibility to QT-interval prolongation (including electrolyte disturbances)

Precautions:

-

Interaction:

-

Warnings:

-

Adverse Effects:

-

Lactations:

-

Special Precautions:

-

Counselling:

-

Side Effects Or Adverse Reactions:

-

Patient And Carer Advice:

-